Blood clots reported in Johnson & Johnson vaccine recipients; four cases were confirmed
DUBLIN: Blood clots have also been reported in Johnson & Johnson COVID-19 vaccine recipients, casting a shadow of fear on COVID defense. Following this, the European Medicines Agency (EMA) has confirmed that it has begun reviewing the safety of the J&J vaccine. It has also decided to suspend the use of J&J vaccine until later this month.
The new report disappoints the world, which has been optimistically waiting for COVID-19 vaccines. As a single dose vaccine, this American vaccine had been widely accepted worldwide. All other vaccines are in two doses.
Four cases of rare blood clots with low blood platelets have been confirmed after receiving the COVID-19 vaccine from US pharma giant J&J. “One case occurred in a clinical trial and three cases occurred during the vaccine rollout in the USA. One of them was fatal,” the EMA said.
The incidence of blood clots similar to the rare side effect of AstraZeneca vaccine was revealed by Amsterdam-based Watchdog. Both jabs use similar adenovirus vector technology.
The EMA says it is reviewing the safety of the J&J vaccine following reports of blood clots. The EU drug watchdog is examining possible links between the Johnson & Johnson vaccine and blood clots. The EMA also said that tits safety committee “has started a review of a safety signal to assess reports of thromboembolic events” in people who received J&J shots.
Following the latest incident, J&J vaccination has been suspended in 27 EU countries until later this month.
Kindly click the link below to join WhatsApp group chat to get important news and breaking news from Irish Samachar
Comments are closed.